CTI BioPharma Profit Margin 2006-2020 | CTIC

Current and historical gross margin, operating margin and net profit margin for CTI BioPharma (CTIC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. CTI BioPharma net profit margin as of March 31, 2020 is -177.54%.
CTI BioPharma Annual Profit Margins
CTI BioPharma Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.075B $0.003B
CTI BioPharma Corp. is a biopharmaceutical company. It is focused on the acquisition, development and commercialization of therapies covering a spectrum of blood-related cancers. The company is heavily focused on marketing its approved therapy Pixuvri in Europe, and on continuing the development of its late-stage development pipeline, including pacritinib. CTI BioPharma Corp., formerly known as Cell Therapeutics, Inc., is headquartered in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.202B 37.57
Takeda Pharmaceutical (TAK) Japan $61.479B 10.77
Astellas Pharma (ALPMY) Japan $33.697B 16.83
Eisai (ESALY) Japan $23.132B 43.09
UCB SA (UCBJF) Belgium $19.548B 0.00
Merck (MKGAF) Germany $13.984B 18.34
Grifols, S.A (GRFS) Spain $13.015B 16.18
Catalent (CTLT) United States $12.040B 46.54
Neurocrine Biosciences (NBIX) United States $11.586B 53.55
Ionis Pharmaceuticals (IONS) United States $7.831B 41.64
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.754B 0.00
Orion OYJ (ORINY) Finland $7.628B 34.18
IPSEN SA ADR (IPSEY) France $6.677B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.602B 10.57
United Therapeutics (UTHR) United States $5.191B 9.84
Evotec AG (EVTCY) Germany $4.079B 65.79
Hypermarcas (HYPMY) Brazil $3.882B 11.81
Nektar Therapeutics (NKTR) United States $3.862B 0.00
ChemoCentryx (CCXI) United States $3.859B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.281B 358.22
PTC Therapeutics (PTCT) United States $3.188B 0.00
FibroGen (FGEN) United States $2.980B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.607B 10.71
Sage Therapeutics (SAGE) United States $1.855B 0.00
Pacira BioSciences (PCRX) United States $1.851B 37.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.782B 0.00
USANA Health Sciences (USNA) United States $1.780B 18.26
Corcept Therapeutics (CORT) United States $1.735B 17.20
Xencor (XNCR) United States $1.724B 0.00
Heron Therapeutics (HRTX) United States $1.652B 0.00
Zogenix (ZGNX) United States $1.612B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.593B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.551B 11.87
Akebia Therapeutics (AKBA) United States $1.516B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.458B 15.71
Portola Pharmaceuticals (PTLA) United States $1.409B 0.00
Karyopharm Therapeutics (KPTI) United States $1.352B 0.00
Translate Bio (TBIO) United States $1.303B 0.00
Tilray (TLRY) Canada $1.228B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.170B 0.00
Indivior (INVVY) United States $1.052B 13.06
Enanta Pharmaceuticals (ENTA) United States $1.030B 45.97
Endo (ENDP) Ireland $0.887B 1.37
ImmunoGen (IMGN) United States $0.816B 0.00
Collegium Pharmaceutical (COLL) United States $0.757B 0.00
Molecular Templates (MTEM) United States $0.709B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.694B 0.00
Aerie Pharmaceuticals (AERI) United States $0.652B 0.00
Ardelyx (ARDX) United States $0.652B 0.00
Radius Health (RDUS) United States $0.587B 0.00
Trillium Therapeutics (TRIL) Canada $0.561B 0.00
Harpoon Therapeutics (HARP) United States $0.544B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.541B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.537B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Siga Technologies (SIGA) United States $0.485B 0.00
DURECT (DRRX) United States $0.459B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.456B 17.82
Catalyst Pharmaceuticals (CPRX) United States $0.446B 10.77
Flexion Therapeutics (FLXN) United States $0.441B 0.00
Organogenesis Holdings (ORGO) United States $0.438B 0.00
Calithera Biosciences (CALA) United States $0.410B 0.00
MEI Pharma (MEIP) United States $0.387B 0.00
Ocular Therapeutix (OCUL) United States $0.376B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.342B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.330B 0.00
Concert Pharmaceuticals (CNCE) United States $0.315B 0.00
Lannett Co Inc (LCI) United States $0.309B 6.77
TherapeuticsMD (TXMD) United States $0.307B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.303B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.288B 0.00
Rafael Holdings (RFL) United States $0.273B 0.00
CASI Pharmaceuticals (CASI) United States $0.266B 0.00
Redhill Biopharma (RDHL) Israel $0.251B 0.00
KalVista Pharmaceuticals (KALV) United States $0.201B 0.00
VAXART, INC (VXRT) United States $0.199B 0.00
PROFOUND MEDICL (PROF) Canada $0.198B 0.00
OptiNose (OPTN) United States $0.198B 0.00
Xeris Pharmaceuticals (XERS) United States $0.193B 0.00
Nature's Sunshine Products (NATR) United States $0.189B 24.87
Jounce Therapeutics (JNCE) United States $0.184B 4.38
Taiwan Liposome (TLC) Taiwan $0.182B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.178B 0.00
IMV INC (IMV) Canada $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.164B 0.00
Altimmune (ALT) United States $0.144B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.130B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.129B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.112B 0.00
Recro Pharma (REPH) United States $0.107B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.106B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Sundial Growers (SNDL) Canada $0.091B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.089B 0.00
CV Sciences (CVSI) United States $0.088B 0.00
Heat Biologics (HTBX) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.082B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.077B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
Onconova Therapeutics (ONTX) United States $0.070B 0.00
Nivalis Therapeutics (ALPN) United States $0.069B 0.00
Biomerica (BMRA) United States $0.064B 0.00
Iterum Therapeutics (ITRM) Ireland $0.061B 0.00
Aclaris Therapeutics (ACRS) United States $0.059B 0.00
MediWound (MDWD) Israel $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.056B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 30.09
IsoRay (ISR) United States $0.049B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 101.00
GTx (ONCT) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
AgeX Therapeutics (AGE) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.040B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.039B 0.00
PolarityTE (PTE) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.037B 7.02
Adamis Pharmaceuticals (ADMP) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.035B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Can-Fite Biopharma (CANF) Israel $0.019B 0.00
Novan (NOVN) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Addex Therapeutics (ADXN) Switzerland $0.000B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00